An overall assessment of the pharmaceutical sector in the Republic of Moldova
was performed during 2011–2012, with the purpose of providing the Ministry of
Health with comprehensive evidence regarding access to essential medicines of
good quality.

This report presents the results, based on a secondary analysis of evidence
collected during a series of assessments conducted by the World Health
Organization Regional Office for Europe in collaboration with the Ministry of
Health of the Republic of Moldova, the Medicines Agency, Nicolae Testemitanu
Republic of Moldova State Medical and Pharmaceutical University, and Health
Action International.

The assessments covered the areas of: public procurement; main regulatory
functions; availability, affordability, prices and price components of essential
medicines; and an evaluation of the essential list of medicines, prescribing
practices and pricing policies. The main recommendations of the report provide
insights into ways of improving regulatory and procurement practices, along with
the best methods to constrain the costs of medicines.